New Zealanders with cancer and rare disorders will benefit from faster, locally delivered genomic testing through a new ...

Use of mosaicism as measured by preimplantation genetic testing for aneuploidy does not predict chances of live birth after IVF.

A blood test clarifies which gene variants truly cause congenital heart defects, linking diagnosis to more precise ...

GeneDx Holdings Corp. (NASDAQ:WGS) is one of the most promising stocks under $100 to buy. On March 10, GeneDx and Zevra ...

Researchers confirmed a four-biomarker model is more informative at younger vs older ages, with slight sex differences.

As the Centers for Medicare and Medicaid Services calls for public feedback on how to stop lab test fraud, experts say a ...

The future of precision medicine will depend less on choosing between genomics or real-world evidence and more on how ...

Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, and ...

Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple ...

Genomics can help to identify people who are more likely to develop glaucoma potentially long before any symptoms of the ...

Millions struggle with depression and anxiety, often enduring long waits for effective treatment. Scientists in Sweden, Denmark, and Germany are developing a genetic test to predict which medications ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved the MyChoice ® CDx ...